Search
Search Constraints
You searched for: Author/Creator Gladman, D DLimit your search
- Gladman, D D [remove] 59
- 616.723005 46
- Rheumatism -- Periodicals 46
- 616.772005 13
- Systemic lupus erythematosus -- Periodicals 13
- PsA, psoriatic arthritis -- RA, rheumatoid arthritis 3
- ACR, American College of Rheumatology -- ADEPT, Adalimumab Effectiveness in Psoriatic Arthritis Trial -- BSA, body surface area -- DLQI, Dermatology Life Quality Index -- FACIT-Fatigue, Functional Assessment of Chronic Illness Therapy—Fatigue -- HAQ DI, Health Assessment Questionnaire Disability Index -- MCID, minimum clinically-important difference -- MCS, mental component summary -- MTX, methotrexate -- PASI, Psoriasis Area and Severity Index -- PCS, physical component summary -- PsA, psoriatic arthritis -- QOL, quality of life -- SF-36, Short-Form 36 Health Survey -- TNF, tumour necrosis factor 1
- ACR, American College of Rheumatology -- AE, adverse event -- ALT, alanine aminotransferase -- anti dsDNA, antibodies to double stranded DNA -- AST, aspartate aminotransferase -- ANAs, antinuclear antibodies -- BSA, body surface area -- HAQ, Health Assessment Questionnaire -- MTX, methotrexate -- NSAIDs, non-steroidal anti-inflammatory drugs -- PASI, Psoriasis Area and Severity Index -- PsA, psoriatic arthritis -- PsARC, Psoriatic Arthritis Response Criteria -- SAE, serious adverse effect -- SF-36, Short Form-36 -- TNFα, tumour necrosis factor α 1
- ACR, American College of Rheumatology -- AJC, active joint count -- ALT, alanine aminotransferase -- ANA, antinuclear antibody -- AST, aspartate aminotransferase -- DMARD, disease modifying antirheumatic drug -- dsDNA, double stranded DNA -- ELISA, enzyme linked immunosorbent assay -- HAQ, Health Assessment Questionnaire -- NSAIDs, non-steroidal anti-inflammatory drugs -- PASI, Psoriasis Area and Severity Index -- PsA, psoriatic arthritis -- PsARC, Psoriatic Arthritis Response Criteria -- RA, rheumatoid arthritis -- RCT, randomised controlled trial -- SF-36, Short Form-36 -- SJC, swollen joint count -- TB, Mycobacterium tuberculosis -- TNFα, tumour necrosis factor α 1
- ACR, American College of Rheumatology -- BASDAI, Bath Ankylosing Spondylitis Disease Activity Index -- CRP, C-reactive protein -- DAS, disease activity score -- ESR, erythrocyte sedimentation rate -- EULAR, European League Against Rheumatism -- GRAPPA, Group for Research and Assessment of Psoriasis and Psoriatic Arthritis -- HAQ, Health Assessment Questionnaire -- OMERACT, Outcome Measures in Rheumatology -- PsA, psoriatic arthritis -- PsARC, psoriatic arthritic response criteria -- RA, rheumatoid arthritis -- VAS, visual analogue scale 1
- AHT, antihypertensive treatment -- CAD, coronary artery disease -- LLA, lipid lowering agent(s) -- SLE, systemic lupus erythematosus -- SLEDAI, SLE Disease Activity Index 1